Embarc Benefit Protection
Product · Financial product (card, account, loan, insurance) by Cigna Group
Making million-dollar gene therapies accessible and affordable.
A financial protection solution that makes million-dollar gene therapies accessible with $0 patient out-of-pocket costs and predictable costs for plan sponsors.
Category: Insurtech
- $0 patient out-of-pocket costs for gene therapies
- Predictable plan costs for employers and sponsors
- Makes million-dollar gene therapies accessible
- Affordability milestone for groundbreaking treatments
Overview
Embarc Benefit Protection is a financial protection solution from The Cigna Group designed to address the high costs of gene therapies. It serves both patients and plan sponsors by making million-dollar treatments accessible while maintaining financial predictability. For patients, the program ensures $0 out-of-pocket costs for covered gene therapies. For employers and plan sponsors, it provides a model for predictable plan costs, mitigating the financial impact of rare and expensive medical innovations. This product represents a significant milestone in healthcare affordability within The Cigna Group's history of innovation.
Financial Protection Features
- $0 Patient Out-of-Pocket: The program makes high-cost gene therapies accessible to patients with $0 out-of-pocket costs.
- Predictable Plan Costs: Plan sponsors and employers receive predictable costs for high-cost therapies, removing financial volatility.
- Gene Therapy Access: The solution is designed specifically to address the financial challenges of million-dollar gene therapies.
Use cases
- Patients access life-changing gene therapies without the burden of million-dollar treatment costs or out-of-pocket expenses.
- Employers and plan sponsors manage their healthcare budgets with predictable costs for high-cost medical treatments.
- Healthcare organizations integrate Embarc Benefit Protection to ensure groundbreaking medical innovations are reachable for those who need them.
Added by AntSpace from public sources (newsroom.thecignagroup.com).